Table 7

Complication rates in PLF patients starting NSAIDs use 90 d to 1 y with different dispensing intervals.

ComplicationNSAIDs Days Dispensed (1–30 d)
N Control N InterventionORCI LowerCI Upper P
Readmission47,75472191.0210.9091.1480.721
Pseudoarthrodesis and hardware failure47,75472191.0390.9811.1000.196
Wound complications47,75472190.9520.8781.0330.239
ComplicationNSAIDs Days Dispensed (31–90 d)
N Control N InterventionORCI LowerCI Upper P
Readmission47,75433141.0830.9211.2730.333
Pseudoarthrodesis and hardware failure47,75433141.0961.0091.1900.030
Wound complications47,75433140.9770.8711.0960.688
ComplicationNSAIDs Days Dispensed (91–180 d)
N Control N InterventionORCI LowerCI Upper P
Readmission47,75418980.9990.8031.2420.990
Pseudoarthrodesis and hardware failure47,7541898 1.154 1.035 1.287 0.010
Wound complications47,75418981.0640.9201.2290.405
ComplicationNSAIDs Days Dispensed (181–365 d)
N Control N InterventionORCI LowerCI Upper P
Readmission47,75411931.3581.0691.7250.012
Pseudoarthrodesis and hardware failure47,75411931.1040.9641.2640.152
Wound complications47,75411931.2991.0971.5370.020
  • Abbreviations: NSAIDs, nonsteroidal anti-inflammatory drugs; PLF, posterior lumbar fusion.

  • Note: Bold values indicate a significance at a Bonferroni-adjusted P value of ≤0.01.